A recent systematic review indicated that IL-6 was inversely correlated with cancer survival in 82 studies out of 101 studies [35], and a study among breast cancer patients observed that high levels of IL-8 was correlated with a higher tumor load, metastasis, accelerated clinical course, and poorer post-relapse survival [36]. This evidence concerns the gene IL6 and breast carcinoma.